Suchergebnisse - "Waskin, Hetty"

PubPharm (22)

1

A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Winchell, G. | de Greef, R. | Ouerdani, A. | +5

2

Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis

enthalten in: Clinical drug investigation | 2023

von Maertens, J. | Rahav, G. | Lee, D. | +10

3

Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)

enthalten in: Journal of the Pediatric Infectious Diseases Society | 2023

von Sferra, T. | Merta, T. | Neely, M. | +10

4

Hepatic safety of the antifungal triazole agent posaconazole : characterization of adverse event reports in a manufacturer's safety database

enthalten in: Expert opinion on drug safety | 2022

von O'Flynn, R. | Zhou, Y. | Waskin, H. | +2

5

Posaconazole versus voriconazole for primary treatment of invasive aspergillosis : a phase 3, randomised, controlled, non-inferiority trial

enthalten in: Lancet (London, England) | 2021

von Maertens, J. | Rahav, G. | Lee, D. | +16

ErratumIn: Lancet. 2021 Aug 7;398(10299):490. - PMID 34364522

6

Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia : an open-label, sequential dose-escalation trial

enthalten in: International journal of antimicrobial agents | 2020

von Groll, A. | Abdel-Azim, H. | Lehrnbecher, T. | +6

7

Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection

enthalten in: Advances in therapy | 2020

von Liu, K. | Wu, D. | Li, J. | +11

8

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia

enthalten in: PloS one | 2019

von Arrieta, A. | Sung, L. | Bradley, J. | +11

9

A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole

enthalten in: Antimicrobial agents and chemotherapy | 2018

von van Iersel, M. | Rossenu, S. | de Greef, R. | +1

10

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Cornely, O. | Robertson, M. | Haider, S. | +17

ErratumIn: J Antimicrob Chemother. 2017 Dec 1;72(12):3501. - PMID 29029280